Fraxiparine 0.2ml. 0.3ml. 0.4ml. 0.6ml. 0.8ml. 1.0ml Injection
PDF Leaflet Revision Date: 29 July 2002
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and treatment of DVT.
Dosage (summary)
0.3 ml (2850 IU AXa) for prophylaxis; adjust for body weight in treatment.
Onset of Action / Duration
Onset: 3 hours, Duration: 18 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended; safety not established.
Key Drug Interactions
- Oral anticoagulants
- Aspirin
- Thrombolytics
Contraindications
- Hypersensitivity to nadroparin
- Active bleeding
- Severe renal impairment
Common side effects
- Bleeding
- Thrombocytopenia
- Injection site reactions
Counselling Points
- Administer subcutaneously only
- Do not rub injection site
- Report any unusual bleeding
Serious warnings
- Risk of thrombocytopenia
- Monitor platelet counts
Important Disclaimer
The Fraxiparine 0.2ml. 0.3ml. 0.4ml. 0.6ml. 0.8ml. 1.0ml Injection professional information leaflet below is the property of Aspenpharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
